BioCentury | Oct 3, 2016
Financial News

Noxxon completes private placement

...II L.P.; Sofinnova Partners; Seventure Partners; Edmond de Rothschild Investment Partners; TVM Capital; CD Ventures; DEWB...
BioCentury | Aug 16, 2004
Company News

MediGene, Munich Biotech deal

...metastatic pancreatic cancer. Munich's investors, which include Global Life Science; HypoVereinsbank (HVB Life Science); and DEWB...
BioCentury | Aug 13, 2004
Company News

MediGene buys Munich Biotech assets

...metastatic pancreatic cancer. Munich's investors, which include Global Life Science; HypoVereinsbank (HVB Life Science); and DEWB...
BioCentury | May 19, 2003
Emerging Company Profile

Corporate Profile

...employees: 68 Funds raised: E38 million ($42 million) Investors: Heidelberg Innovation; Deutsche Bank; Sal. Oppenheim; DEWB...
BioCentury | Apr 7, 2003
Company News

Epidauros management update

...of the executive board; and Andreas Schulze, head of the biotech team of venture firm DEWB...
BioCentury | Apr 2, 2003
Company News

Epidauros CEO steps down

...Germany) has left the company. Andreas Schulze, head of the biotech team of venture firm DEWB...
Items per page:
1 - 6 of 6
BioCentury | Oct 3, 2016
Financial News

Noxxon completes private placement

...II L.P.; Sofinnova Partners; Seventure Partners; Edmond de Rothschild Investment Partners; TVM Capital; CD Ventures; DEWB...
BioCentury | Aug 16, 2004
Company News

MediGene, Munich Biotech deal

...metastatic pancreatic cancer. Munich's investors, which include Global Life Science; HypoVereinsbank (HVB Life Science); and DEWB...
BioCentury | Aug 13, 2004
Company News

MediGene buys Munich Biotech assets

...metastatic pancreatic cancer. Munich's investors, which include Global Life Science; HypoVereinsbank (HVB Life Science); and DEWB...
BioCentury | May 19, 2003
Emerging Company Profile

Corporate Profile

...employees: 68 Funds raised: E38 million ($42 million) Investors: Heidelberg Innovation; Deutsche Bank; Sal. Oppenheim; DEWB...
BioCentury | Apr 7, 2003
Company News

Epidauros management update

...of the executive board; and Andreas Schulze, head of the biotech team of venture firm DEWB...
BioCentury | Apr 2, 2003
Company News

Epidauros CEO steps down

...Germany) has left the company. Andreas Schulze, head of the biotech team of venture firm DEWB...
Items per page:
1 - 6 of 6